|
A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate Clinical research trials and A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate. A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate clinical trial. Participants typically obtain the most effective healthcare available for their A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate  A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate
A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate
For Condition: Rheumatoid Arthritis
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: The purpose of this clinical research study is to learn if BMS-188667 in combination with methotrexate is better than methotrexate alone in subjects that have active rheumatoid arthritis and are not responding to methotrexate. The safety of this treatment will also be studied.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Rheumatoid Arthritis for greater than 1 year from the time of initial diagnosis of RA. - Patients must have been taking methotrexate for at least 3 months with at least a weekly dose of 15 mg.
Total Enrollment:
Location and Contact Information:
Local Institution
Duncansville, Pennsylvania,
United States
Local Institution
Sellersville, Pennsylvania,
United States
Local Institution
Irvine, California,
United States
Local Institution
Binghamton, New York,
United States
Local Institution
Oklahoma City, Oklahoma,
United States
Local Institution
Coeur d'Alene, Maryland,
United States
Local Institution
Albany, New York,
United States
Local Institution
Palm Harbor, Florida,
United States
Local Institution
Corona, California,
United States
Local Institution
Willow Grove, Pennsylvania,
United States
Local Institution
Sarasota, Florida,
United States
Local Institution
Scottsdale, Arizona,
United States
Local Institution
Rockford, Illinois,
United States
Local Institution
Lincoln, Nebraska,
United States
Local Institution
New Brunswick, New Jersey,
United States
Local Institution
New York City, New York,
United States
Local Institution
Wichita, Kansas,
United States
Local Institution
Birmingham, Alabama,
United States
Local Institution
Cumberland, Maryland,
United States
Local Institution
Syracuse, New York,
United States
Local Institution
Aurora, Colorado,
United States
Local Instituton
St. Petersburg, Florida,
United States
Local Institution
Colorado Springs, Colorado,
United States
Local Institution
Duluth, Minnesota,
United States
Local Institution
Chicago, Illinois,
United States
Local Instituton
Rancho Mirage, California,
United States
Local Institution
Long Beach, California,
United States
Local Institution
Bronx, New York,
United States
Local Institution
Norristown, Pennsylvania,
United States
Local Institution
Denver, Colorado,
United States
Local Institution
Phoenix, Arizona,
United States
Local Institution
Austin, Texas,
United States
Local Institution
Arlington, Virginia,
United States
Local Institution
Ft. Lauderdale, Florida,
United States
Local Institution
San Antonio, Texas,
United States
Local Institution
Wilmington, North Carolina,
United States
Local Institution
Gainesville, Florida,
United States
Local Institution
Springfield, Massachusetts,
United States
Local Institution
Milwaukee, Wisconsin,
United States
Local Institution
Hamden, Connecticut,
United States
Local Institution
Cincinnati, Ohio,
United States
Local Institution
Washington D.C., District of Columbia,
United States
Local Institution
La Jolla, California,
United States
Local Institution
North Charleston, South Carolina,
United States
Local Institution
Huntsville, Alabama,
United States
Local Institution
Albuquerque, New Mexico,
United States
Local Institution
Mobile, Alabama,
United States
Local Institution
Irvine, California,
United States
Local Institution
Mineola, New York,
United States
Additional Information:
Study ID Numbers: IM101-102;
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00048568
Other Rheumatoid Arthritis Studies:
1. Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis
2. Treatment of Rheumatoid Arthritis with Marine and Botanical Oils
3. A Phase 2 open-label clinical study using intravenous Paxceed™ to treat patients with rheumatoid arthritis
4. Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
5. Coping Skills Training for Early Rheumatoid Arthritis
Related Studies:
Other Rheumatoid Arthritis Clinical Trials
Other California Clinical Trials
Other Corona Clinical Trials
A Phase III Study of BMS-188667 in patients with active rheumatoid arthritis and inadequate response to methotrexate
|
|
|
|
|
|
|
|
